Hypertension Clinical Trials in Seoul
21 recruitingSeoul, South Korea
Showing 1–20 of 21 trials
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1153 locationsNCT07064473
Recruiting
Phase 3
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Pulmonary Hypertension Associated With HFpEF
Tenax Therapeutics, Inc.540 enrolled92 locationsNCT07288398
Recruiting
Phase 3
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option
Hypertension, Pulmonary
Actelion280 enrolled43 locationsNCT05179876
Recruiting
Not Applicable
CART BP Pro-Guided Blood Pressure Management in Patients With Uncontrolled Hypertension: A Multicenter Randomized Controlled Trial
Hypertension
Korea University Anam Hospital400 enrolled3 locationsNCT07465549
Recruiting
Phase 3
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
Pulmonary Arterial Hypertension
Merck Sharp & Dohme LLC815 enrolled63 locationsNCT07218029
Recruiting
Phase 2
A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.
Chronic Kidney Disease and Hypertension
AstraZeneca218 enrolled70 locationsNCT07222917
Recruiting
Phase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
AstraZeneca5,000 enrolled753 locationsNCT06742723
Recruiting
Phase 3
Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Ocular HypertensionPrimary Open Angle Glaucoma (POAG)
Huons Co., Ltd.206 enrolled1 locationNCT07335211
Recruiting
Not Applicable
A First-in-human Study of HyperQureTM", Laparoscopic Renal Denervation Therapy in Patient With Resistant Hypertension
Resistant Hypertension
DeepQure Inc.10 enrolled7 locationsNCT06216808
Recruiting
Phase 3
A Randomized, Double-blind, Multi-center, Active-controlled, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of THP-00101, THP-00102, and THP-00103 in Subjects With T2DM and Essential Hypertension
HypertensionType 2 Diabetes
THPharm Corp.221 enrolled2 locationsNCT06647745
Recruiting
An OS to Evaluate Effectiveness and Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ
Hypertension,Essential
Boryung Pharmaceutical Co., Ltd20,000 enrolled1 locationNCT05413057
Recruiting
Phase 3
Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia
HypertensionDyslipidemia
JW Pharmaceutical162 enrolled1 locationNCT06643130
Recruiting
Not Applicable
Validation Study of CART BP as a Wearable Cuffless Blood Pressure Monitor
Blood Pressure, HighHypertensionBlood Pressure+2 more
Sky Labs50 enrolled1 locationNCT06513975
Recruiting
Phase 2
Efficacy and Safety of SPC1001 in Patients With Essential Hypertension
Cardiovascular DiseasesCardiologyHypertension,Essential
Shin Poong Pharmaceutical Co. Ltd.252 enrolled1 locationNCT06826872
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227B
Essential Hypertension
Addpharma Inc.251 enrolled1 locationNCT06441630
Recruiting
Not Applicable
Exploring Approaches With Lower Targets of Blood Pressure and Lipid for Improving Renal Outcome in Advanced Chronic Kidney Disease
HypertensionChronic Kidney DiseasesDyslipidemias
Yonsei University642 enrolled1 locationNCT06322056
Recruiting
Phase 4
Efficacy and Safety of Telmisartan Compared With Losartan
HypertensionDiabetic Nephropathies
Chong Kun Dang Pharmaceutical98 enrolled1 locationNCT06431477
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy
Essential HypertensionType 2 Diabetes Mellitus
Boryung Pharmaceutical Co., Ltd276 enrolled2 locationsNCT06220773
Recruiting
Phase 3
Efficacy and Safety of AJU-C52 in Essential Hypertension Patients
Essential Hypertension
AJU Pharm Co., Ltd.190 enrolled1 locationNCT06416865
Recruiting
Phase 3
Phase III Study to Evaluate the Efficacy and Safety of AD-209
Hypertension,Essential
Addpharma Inc.280 enrolled1 locationNCT06348576